Shanghai RAAS Blood Products
002252.SZ
#3278
Rank
NZ$8.36 B
Marketcap
NZ$1.27
Share price
-0.43%
Change (1 day)
-25.27%
Change (1 year)
Categories

Earnings for Shanghai RAAS Blood Products (002252.SZ)

Earnings in 2026 (TTM): NZ$0.36 Billion

According to Shanghai RAAS Blood Products's latest financial reports the company's current earnings are NZ$0.90 Billion. In 2024 the company made an earning of NZ$0.66 Billion, an increase over its 2023 earnings that were of NZ$0.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Shanghai RAAS Blood Products from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.36 B
2024 NZ$0.66 B16.84%
2023 NZ$0.56 B-7.63%
2022 NZ$0.61 B42.24%
2021 NZ$0.43 B10.74%
2020 NZ$0.39 B101.27%
2019 NZ$0.19 B-127.19%
2018 -NZ$0.72 Billion-265.98%
2017 NZ$0.42 B-29.79%
2016 NZ$0.61 B-12.28%
2015 NZ$0.69 B278.74%
2014 NZ$0.18 B241.48%
2013 NZ$53.97 M-27.95%
2012 NZ$74.91 M11.6%
2011 NZ$67.13 M10.64%
2010 NZ$60.67 M40.24%
2009 NZ$43.26 M31.73%
2008 NZ$32.84 M33.29%
2007 NZ$24.64 M